Sicart Associates’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,650
Closed -$234K 125
2020
Q4
$234K Buy
+1,650
New +$234K 0.06% 100